FDA Approves Microbiome Therapeutic Vowst to Prevent Recurrence of C. difficile Infections in Adults
Seres Therapeutics and Nestlé Health Science celebrate the FDA's approval of Vowst, a first-of-its-kind orally administered microbiota-based therapeutic set to transform the lives of patients with ...
SAINT-PREX, Switzerland & ROSEVILLE, Minn.--(BUSINESS WIRE)--Ferring Pharmaceuticals and Rebiotix, a Ferring Company, today presented results from the pivotal Phase 3 PUNCH™ CD3 clinical trial, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback